US 10604585
Modulation of PTPRA to treat arthritis
granted A61PA61P19/02
Quick answer
US patent 10604585 (Modulation of PTPRA to treat arthritis) held by The Regents of the University of California expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P19/02